No takes yet. Share an insight, caveat, or question.
Randomized trial reports failure-free survival in newly diagnosed patients with low-risk embryonal rhabdomyosarcoma, suggesting effective treatment with reduced toxicity.
Raney et al. (2011) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: